Issued Patents 2019
Showing 1–10 of 10 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10472359 | Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity | Peng Li, Qiang Zhang, Robert E. Davis | 2019-11-12 |
| 10464938 | Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof | John Charles Tomesch, Peng Li, Wei Yao, Qiang Zhang, James David Beard +2 more | 2019-11-05 |
| 10398698 | Uses | Robert E. Davis | 2019-09-03 |
| 10322134 | Methods | Kimberly VANOVER, Peng Li, Sharon Mates, Robert E. Davis | 2019-06-18 |
| 10300064 | Organic compounds | Peng Li, Hailin Zheng, Gretchen SNYDER, Joseph Hendrick | 2019-05-28 |
| 10285992 | Combinations of PDE1 inhibitors and NEP inhibitors and associated methods | Peng Li | 2019-05-14 |
| 10238660 | Organic compounds | Allen A. Fienberg, Sharon Mates | 2019-03-26 |
| 10221176 | Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof | John Charles Tomesch, Peng Li, Wei Yao, Qiang Zhang, James David Beard +2 more | 2019-03-05 |
| 10188758 | Organic compounds | Peng Li, Jun Zhao | 2019-01-29 |
| 10183023 | Uses | — | 2019-01-22 |